Molecular Insight Hits USPTO Over Patent Terms
Molecular Insight Pharmaceuticals Inc. has filed two suits against the U.S. Patent and Trademark Office over its refusal to extend the term patents owned or licensed by the drug company in...To view the full article, register now.
Already a subscriber? Click here to view full article